AstraZeneca secures orders for virus vaccine under testing

AstraZeneca secures orders for virus vaccine under testing
LONDON -- Drug maker AstraZeneca said Thursday it had secured its first agreements for 400 million doses of a COVID-19 vaccine it is testing, bolstered by an investment from the U.S. vaccine agency.

The Anglo-Swedish company reported it had received more than $1 billion from the U.S. Biomedical Advanced Research and Development Authority for the development, production and delivery of the vaccine, starting this fall.

The investment will accelerate the development and production of the vaccine, AstraZeneca Chief Executive Pascal Soriot said. It had already joined forces with the British government and is in discussions with the Serum Institute of India and other potential partners to increase production and distribution.

"We will do everything in our power to make this vaccine quickly and widely available," Soriot said.

Pharmaceutical companies including also Moderna and Sanofi are racing to develop and produce a vaccine against the new coronavirus as experts say it will be crucial to allowing countries to ease their lockdowns and restrictions on public life.

In a statement as markets opened , AstraZeneca said it has now secured manufacturing capacity for 1 billion doses and aims to secure further agreements to expand capacity further over the next months "to ensure the delivery of a globally accessible vaccine."

The company also finalized its licence agreement with Oxford University for the vaccine, now known as AZD1222.

The vaccine was developed by Oxford University s Jenner Institute, working with the Oxford Vaccine Group.

Testing of the experimental COVID-19 vaccine began in healthy volunteers in Britain in April with over 1,000 healthy volunteers aged 18 to 55.

Data from the trial is expected soon and if results are positive, further trials will take place in other countries..

"AstraZeneca recognizes that the vaccine may not work," the statement said, "but is committed to progressing the clinical program with speed and scaling up manufacturing at risk."
Read more on CTVnews
News Topics :
Similar Articles :
LONDON Drug maker AstraZeneca secured its first agreements Thursday for 400 million doses of a COVID 19 vaccine, bolstered by an investment from the U.S. vaccine agency. The Anglo Swedish company...
BENGALURU/LONDON Reuters The United States has secured almost a third of AstraZeneca’s one billion possible COVID 19 vaccine doses by pledging up to $1.2 billion, as the world’s biggest powers...
LONDON British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10, 000 people to determine if...
Reuters AstraZeneca expects to be able to deliver a billion doses of a possible COVID 19 vaccine this year and next if tests are successful, adding on Thursday it should...
Reuters The United States will pump up to $1.2 billion into developing AstraZeneca’s potential COVID 19 vaccine and said on Thursday it would order 300 million doses, as the White...